Dr. Amarinder S. Bindra
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 24
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 223
Licensed in Texas since 2014, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
TX license Q1095 (first issued 2014; active) - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor University Medical Center Dallas, TX
- Willis Knighton Medical Center Shreveport, LA
- Baylor Scott & White Heart & Vascular Hospital - Dallas Dallas, TX
Medical groups
- Healthtexas Provider Network (2,697 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 223
- Services billed
- 442
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 102 | 100 |
| Established patient office or other outpatient visit, 30-39 minutes | 92 | 61 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 90 | 33 |
| Established patient office or other outpatient visit, 40-54 minutes | 44 | 38 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 44 | 20 |
| Critical care, first 30-74 minutes | 15 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Entresto (sacubitril/valsartan) Other prescribers in Dallas, TX | 165 |
| Spironolactone Other prescribers in Dallas, TX | 143 |
| Jardiance (empagliflozin) Other prescribers in Dallas, TX | 126 |
| Carvedilol Other prescribers in Dallas, TX | 120 |
| Metoprolol Succinate Other prescribers in Dallas, TX | 100 |
| Eplerenone Other prescribers in Dallas, TX | 89 |
| Rosuvastatin Calcium Other prescribers in Dallas, TX | 81 |
| Warfarin Sodium Other prescribers in Dallas, TX | 78 |
| Digoxin Other prescribers in Dallas, TX | 70 |
| Sirolimus | 65 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 61 payments worth $26,590 in total to this clinician.
| Cvrx, Inc. | $26,008 |
|---|---|
| Abbott Laboratories | $201 |
| Merck Sharp & Dohme LLC | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $66.40 |
| Novartis Pharmaceuticals Corporation | $65.80 |
| Kestra Medical Technology Services, Inc. | $46.69 |
| Abiomed | $45.25 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $25.67 |
| Consulting Fee | $20,625 |
|---|---|
| Travel and Lodging | $3,467 |
| Food and Beverage | $2,498 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Cvrx, Inc. Jul 2, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $5,000 |
| Cvrx, Inc. Apr 11, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $4,000 |
| Cvrx, Inc. May 29, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $4,000 |
| Cvrx, Inc. Aug 8, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $4,000 |
| Cvrx, Inc. Apr 3, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $3,625 |
| Cvrx, Inc. Apr 16, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Tulsa, OK | $800 |
| Cvrx, Inc. May 19, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Tulsa, OK | $741 |
| Cvrx, Inc. Nov 25, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Orlando, FL | $515 |
| Cvrx, Inc. Feb 11, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Dallas, TX | $501 |
| Cvrx, Inc. Apr 11, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to El Paso, TX | $304 |
All 20 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Cvrx, Inc. Nov 25, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Orlando, FL | $515 |
| Cvrx, Inc. Nov 25, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Orlando, FL | $34.00 |
| Cvrx, Inc. Aug 8, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $4,000 |
| Cvrx, Inc. Jul 11, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Monroe, LA | $194 |
| Cvrx, Inc. Jul 2, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $5,000 |
| Cvrx, Inc. Jun 18, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Tulsa, OK | $35.00 |
| Cvrx, Inc. Jun 18, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Arlington, VA | $26.00 |
| Cvrx, Inc. Jun 3, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Arlington, VA | $10.00 |
| Cvrx, Inc. May 29, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $4,000 |
| Cvrx, Inc. May 29, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to McAllen, TX | $160 |
| Cvrx, Inc. May 19, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Tulsa, OK | $741 |
| Cvrx, Inc. May 19, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Arlington, VA | $26.00 |
| Cvrx, Inc. Apr 28, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Tulsa, OK | $68.80 |
| Cvrx, Inc. Apr 28, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Arlington, VA | $26.00 |
| Cvrx, Inc. Apr 16, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Tulsa, OK | $800 |
| Cvrx, Inc. Apr 16, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Arlington, VA | $26.00 |
| Cvrx, Inc. Apr 11, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $4,000 |
| Cvrx, Inc. Apr 11, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to El Paso, TX | $304 |
| Cvrx, Inc. Apr 3, 2025 | Consulting Fee Barostim Neo System · Heart Failure and Hypertension | $3,625 |
| Cvrx, Inc. Feb 11, 2025 | Travel and Lodging Barostim Neo System · Heart Failure and Hypertension · travel to Dallas, TX | $501 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $20,322 in research payments for these studies, mostly to the institutions running them.
- Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics (USA) Inc. · Recruiting · NCT05064709
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.